3629 results for «2284»
3629 results
Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
07 Oct 2022 – From AICT-AsiaPCR 2022
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
Complications: cases of wire entrapment, stent dislodgement, an entangled Impella device and more
16 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to learn how to face various complications, thanks to a selection of cases presented at GulfPCR-GIM 2021: a wire entrapment, a guide-wire fracture, a dissection and a loss of flow, a stent dislodgement, as well as an entangled Impella device.
Cases on CTO
16 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover 3 CTO cases unveiled at GulfPCR-GIM 2021: a successful CTO left circumflex PCI with periprocedural cardiac tamponade, a dynamic coronary roadmap as a guidance tool in CTO LAD recanalisation, as well as a complicated CTO to right coronary artery.
Coronary aneurysms: diagnosis, treatment and complications
12 May 2021 – From EuroPCR 2021
Watch this session to increase your knowledge of coronary aneurysms: learn how to avoid side-branch occlusion thanks to covered stent shortening, how to treat left main coronary artery aneurysm, how to handle huge coronary aneurysm in case of DES, and much more!
Coronary physiology in STEMI: is OpSens OptoWire III a game-changer in complete revascularisation?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Engstrom, Zsolt Piroth, Jacques Monsegu and Giuseppe Biondi-Zoccai in order to get an update on the latest evidence in physiology-guided full revascularisation in STEMI patients, to discover how the innovative physiology wire, OptoWire III from OpSens may lower the barriers to approach...
How CT fusion can empower your structural heart procedures
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Erwan Donal, Julia Grapsa and Ronak Rajani in order to learn how the novel tools in 4D TEE can help improving visualisation, navigation and communication within the heart team and how to better plan your structural heart procedures with Echo...
Contemporary adoption of invasive coronary physiology with microcatheter-based technology
19 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Bernard De Bruyne, Jeroen Sonck, Simone Biscaglia, Salvatore Brugaletta and Carlos Collet in order to understand the role of microcatheter-based physiology also through a critical appraisal of the available literature, to know how to correctly adopt the novel TruePhysio microcatheter, and...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries:
- Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
- Anatomical snuffbox for coronary angiography and interventions
- Randomized comparison between Radial and Femoral Large-bore access Complex PCI
- Experience with BRS for treatment of de novo native peripheral artery lesions
- Clinical validation of...
Left atrial appendage closure (LAAc) for stroke prevention - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to select the most suitable patients for LAA closure, to develop an approach to appropriate device selection and procedural planning, to share step-by-step implementation of procedural plans and to explore optimal post procedure follow-up and care.
This session...
Latest clinical evidence and practical aspects to start Reducer therapy in your centre
20 May 2021 – From EuroPCR 2021
Watch this session presented by Stefan Verheye, Francesco Giannini, Martine Gilard, Romain Didier, Tommaso Gori and Jonathan Hill in order to assess whether Reducer therapy can help your patients with refractory angina, to understand the tips and tricks of the Reducer implant, and to get a glimpse into...
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...
Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.
